Drug General Information
Drug ID
D0K5QW
Former ID
DNC000762
Drug Name
I-309
Drug Type
Small molecular drug
Indication Discovery agent Investigative [542979]
Structure
Download
2D MOL

3D MOL

Formula
C12H8Br2O2S
Canonical SMILES
C1=CC(=CC=C1S(=O)(=O)C2=CC=C(C=C2)Br)Br
InChI
1S/C12H8Br2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H
InChIKey
QBNABJXQGRVIRA-UHFFFAOYSA-N
CAS Number
CAS 26305-03-3
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) C-C chemokine receptor type 8 Target Info Binder [538110]
KEGG Pathway Cytokine-cytokine receptor interaction
Chemokine signaling pathway
Viral carcinogenesis
NetPath Pathway IL2 Signaling Pathway
PANTHER Pathway Inflammation mediated by chemokine and cytokine signaling pathway
Reactome Chemokine receptors bind chemokines
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 542979(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 812).
Ref 538110The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol. 1998 Jul 15;161(2):547-51.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.